Chronic myeloid leukemia following the treatment of rectal adenocarcinoma

Author： Kadikoylu Gurhan   Yavasoglu Irfan   Barutca Sabri   Meydan Nezih   Bolaman Zahit  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.25, Iss.4, 2008-12, pp. : 467-470

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ever-advancing chronic myeloid leukemia treatment

By Kimura Shinya   Ando Toshihiko   Kojima Kensuke  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 3-9

Springer Publishing Company

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 8, 2009-10 ,pp. : 853-863

Bentham Science Publishers

Access to resources Recommend Favorite

Decitabine for the treatment of atypical chronic myeloid leukemia: A report of two cases

By          

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 689-692

Spandidos Publications

Access to resources Recommend Favorite

Imatinib and chronic myeloid leukemia: close to the bone

By Terpos Evangelos  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1581-1582

Informa Healthcare

Access to resources Recommend Favorite

Chronic Myeloid Leukemia: The Value of Tyrosine Kinase Inhibition

By Tariq I. Mughal   John M. Goldman  

American Journal of Cancer, Vol. 2, Iss. 5, 2003-01 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite